Shareholder Vote

Title of each class Capital stock, par value $.20 per share Trading symbol IBM Common Stock     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549         FORM 8-K       CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934    Date of Report : April 26, 2022 (Date of earliest event reported)       INTERNATIONAL BUSINESS MACHINES CORPORATION (Exact name of registrant as specified in its charter)       New York   1-2360   13-0871985 (State of Incorporation)   (Commission File Number)   (IRS employer Identification No.)   One New Orchard Road     Armonk , New York   10504 (Address of principal executive offices)   (Zip Code)   914 - 499-1900 (Registrant’s telephone number)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Capital stock, par value $.20 per share   IBM   New York Stock Exchange         NYSE Chicago 2.625% Notes due 2022   IBM 22A   New York Stock Exchange 1.250% Notes due 2023   IBM 23A   New York Stock Exchange 0.375% Notes due 2023   IBM 23B   New York Stock Exchange 1.125% Notes due 2024   IBM 24A   New York Stock Exchange 2.875% Notes due 2025   IBM 25A   New York Stock Exchange 0.950% Notes due 2025   IBM 25B   New York Stock Exchange 0.875% Notes due 2025   IBM 25C   New York Stock Exchange 0.300% Notes due 2026   IBM 26B   New York Stock Exchange 1.250% Notes due 2027   IBM 27B   New York Stock Exchange 0.300% Notes due 2028   IBM 28B   New York Stock Exchange 1.750% Notes due 2028   IBM 28A   New York Stock Exchange 1.500% Notes due 2029   IBM 29   New York Stock Exchange 0.875% Notes due 2030   IBM 30   New York Stock Exchange 1.750% Notes due 2031   IBM 31   New York Stock Exchange 0.650% Notes due 2032   IBM 32A   New York Stock Exchange 1.250% Notes due 2034   IBM 34   New York Stock Exchange 1.200% Notes due 2040   IBM 40   New York Stock Exchange 7.00% Debentures due 2025   IBM 25   New York Stock Exchange 6.22% Debentures due 2027   IBM 27   New York Stock Exchange 6.50% Debentures due 2028   IBM 28   New York Stock Exchange 7.00% Debentures due 2045   IBM 45   New York Stock Exchange 7.125% Debentures due 2096   IBM 96   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨             Item 5.07. Submission of Matters to a Vote of Security Holders.   (a) International Business Machines Corporation (IBM) held its Annual Meeting of Stockholders on April 26, 2022. Below are the final voting results. For more information on the following proposals, see IBM’s proxy statement dated March 7, 2022, the relevant portions of which are incorporated herein by reference.   (b) Election of Directors for a Term of One Year:   DIRECTOR   FOR     AGAINST     ABSTAIN     BROKER NON-VOTES   T. Buberl     512,637,798       19,408,925       4,938,318       156,937,839   D.N. Farr     519,777,197       12,298,952       4,908,892       156,937,839   A. Gorsky     485,553,123       46,605,407       4,826,511       156,937,839   M. Howard     523,505,493       9,039,546       4,440,002       156,937,839   A. Krishna     496,032,233       35,527,242       5,425,566       156,937,839   A.N. Liveris     350,899,075       180,880,781       5,205,185       156,937,839   F.W. McNabb III     522,234,880       9,685,670       5,064,491       156,937,839   M.E. Pollack     522,938,417       9,585,516       4,461,108       156,937,839   J.R. Swedish     521,023,719       10,955,761       5,005,561       156,937,839   P.R. Voser     519,656,314       12,350,599       4,978,128       156,937,839   F.H. Waddell     513,406,371       18,585,003       4,993,667       156,937,839   A.W. Zollar     517,825,968       14,323,443       4,835,630       156,937,839     Ratification of Appointment of Independent Registered Public Accounting Firm:   For     656,967,636       95.2 % Against     32,830,338       4.8 % Abstain     4,124,906             Management Proposal on Advisory Vote on Executive Compensation (Say on Pay):   For     473,874,456       89.6 % Against     55,096,187       10.4 % Abstain     8,014,398           Broker Non-Votes     156,937,839             Stockholder Proposal on Stockholder Special Meeting Right:   For     187,771,875       35.5 % Against     340,686,181       64.5 % Abstain     8,526,985           Broker Non-Votes     156,937,839             Stockholder Proposal to Have an Independent Board Chairman:   For     211,119,750       39.8 % Against     318,877,167       60.2 % Abstain     6,988,124           Broker Non-Votes     156,937,839             Stockholder Proposal Requesting a Public Report on the Use of Concealment Clauses:   For     339,827,195       64.7 % Against     185,380,818       35.3 % Abstain     11,777,028           Broker Non-Votes     156,937,839             2     IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.   3     SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.   Date:  April 29, 2022               By: /s/ Frank Sedlarcik     Frank Sedlarcik     Vice President, Assistant General Counsel and Secretary   4